{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Hariharaputhiran S"],"funding":["National Heart Foundation of Australia"],"pagination":["1519-1528"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9804480"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["24(9)"],"pubmed_abstract":["<h4>Aims</h4>Contemporary long-term survival following a heart failure (HF) hospitalization is uncertain. We evaluated survival up to 10 years after a HF hospitalization using national data from Australia and New Zealand, identified predictors of survival, and estimated the attributable loss in life expectancy.<h4>Methods and results</h4>Patients hospitalized with a primary diagnosis of HF from 2008-2017 were identified and all-cause mortality assessed by linking with Death Registries. Flexible parametric survival models were used to estimate survival, predictors of survival and loss in life expectancy. A total of 283 048 patients with HF were included (mean age 78.2 ± 12.3 years, 50.8% male). Of these, 48.3% (48.1-48.5) were surviving by 3 years, 34.1% (33.9-34.3) by 5 years and 17.1% (16"],"journal":["European journal of heart failure"],"pubmed_title":["Long-term survival and life expectancy following an acute heart failure hospitalization in Australia and New Zealand."],"pmcid":["PMC9804480"],"funding_grant_id":["101186"],"pubmed_authors":["Peng Y","Hossain S","Chan W","Adams R","Ranasinghe I","Ngo L","Ali A","Visvanathan R","Hariharaputhiran S"],"additional_accession":[]},"is_claimable":false,"name":"Long-term survival and life expectancy following an acute heart failure hospitalization in Australia and New Zealand.","description":"<h4>Aims</h4>Contemporary long-term survival following a heart failure (HF) hospitalization is uncertain. We evaluated survival up to 10 years after a HF hospitalization using national data from Australia and New Zealand, identified predictors of survival, and estimated the attributable loss in life expectancy.<h4>Methods and results</h4>Patients hospitalized with a primary diagnosis of HF from 2008-2017 were identified and all-cause mortality assessed by linking with Death Registries. Flexible parametric survival models were used to estimate survival, predictors of survival and loss in life expectancy. A total of 283 048 patients with HF were included (mean age 78.2 ± 12.3 years, 50.8% male). Of these, 48.3% (48.1-48.5) were surviving by 3 years, 34.1% (33.9-34.3) by 5 years and 17.1% (16","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Sep","modification":"2025-04-05T12:09:47.51Z","creation":"2025-04-05T12:09:47.51Z"},"accession":"S-EPMC9804480","cross_references":{"pubmed":["35748124"],"doi":["10.1002/ejhf.2595"]}}